MIST: Milestone Pharmaceuticals Inc

1.49 USD 0.04 (2.61%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de MIST de hoy ha cambiado un -2.61%. En este caso, el precio mínimo en el mercado ha alcanzado 1.47, mientras que el máximo ha alcanzado 1.53.

Siga la dinámica de la pareja de divisas Milestone Pharmaceuticals Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

MIST News

Seeking Alpha 18:16 Milestone Pharmaceuticals Remains A Buying Opportunity Despite Recent Dilution (MIST)
TipRanks 01:23 Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today? - TipRanks.com
Investing 20:30 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.63%
Benzinga 18:37 Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge - Federal Agricultural (NYSE:AGM), MiNK Therapeutics (NASDAQ:INKT)
Benzinga 16:22 Why Is Milestone Pharmaceuticals Stock Plunging On Friday? - Milestone Pharmaceuticals (NASDAQ:MIST)
TipRanks 15:52 Morning News Wrap-Up: Friday’s Biggest Stock Market Stories! - TipRanks.com
Benzinga 14:41 Dow Dips Over 200 Points; Levi Strauss Posts Upbeat Earnings - Concorde Intl Gr (NASDAQ:CIGL), Above Food Ingredients (NASDAQ:ABVE)
Investing 13:41 Milestone Pharmaceuticals prices $52.5 million public offering
Investing 12:54 Milestone Pharmaceuticals stock plunges on public offering announcement
Investing 10:05 FDA sets December 13 action date for Milestone’s CARDAMYST
Investing 10:04 Milestone Pharmaceuticals announces public offering of shares and warrants
Seeking Alpha 14:01 Watch Milestone Pharmaceuticals For (Likely) Upcoming FDA Approval For Cardamyst (MIST)
Investing 11:29 Milestone Pharmaceuticals resubmits Cardamyst filing after FDA response
Investing 12:09 Milestone Pharmaceuticals submits response to FDA for PSVT drug
Investing 12:32 Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Seeking Alpha 14:26 Milestone Pharmaceuticals: Opportunity To Buy On Etripamil's CRL In PSVT
Seeking Alpha 18:30 Stock Picks From Seeking Alpha's March 2025 New Analysts
Benzinga 16:14 Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher - AAR (NYSE:AIR), Abacus Global Management (NASDAQ:ABL)
Benzinga 13:58 Why Is Milestone Pharmaceuticals Stock Plunging Today? - Milestone Pharmaceuticals (NASDAQ:MIST)
Benzinga 13:41 Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected - Lexicon Pharmaceuticals (NASDAQ:LXRX), DBV Technologies (NASDAQ:DBVT)
Seeking Alpha 19:18 Milestone Pharmaceuticals: A Compelling Value Proposition For Patients And Payers

Rango diario

1.47 1.53

Rango anual

0.63 2.75

Cierres anteriores: 1.46
Open: 1.53

Bid: 1.49
Ask: 1.79

Low: 1.47
High: 1.53

Volumen: 487

Cambio diario: -2.61%
Cambio mensual: -23.59%

Cambio a 6 meses: -23.59%
Cambio anual: 2.05%

30 julio, miércoles